Alkem Laboratories shares gain on antifungal drug deal with Biosergen AB
Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups in the US and EU via pivotal trials.
Alkem Laboratories appoints Dr Vikas Gupta as CEO effective Sept 22
Gupta holds an M.B.B.S degree from University College of Medical Sciences, Delhi University and has over to decades of experience in pharmaceutical sector
Alkem recalled 99,516 sachets of antibiotic used to treat bladder infections and Caplin recalled 19,820 vials of heart medication according to US FDA Enforcement Report
Lupin, Glenmark Pharma, 7 BSE Healthcare stocks which hit 52-week high on Wednesday
The data was sourced from BSE at 2.50 pm, and the updates from the real-time data could come with a lag. The below data also pertains only to the time at which it was taken.
IRFC, MRF among 8 midcap stocks which hit new 52-week high on Thursday
August 3 witnessed a remarkable surge in the BSE MidCap segment as several stocks hit new 52-week highs, displaying strong bullish momentum despite market fluctuations.
Top drugmakers bet on trade generics to grow beyond metros
Trade generics are branded medicines that are not promoted to physicians but are directly sold through retailers and distributors. In India, trade generics have a market share of 20% by volume and 5-6% by value, according to data and analytics firm IQVIA. The segment is growing around 14-15% per annum.
Cipla, Natco Pharma among 10 overbought stocks with RSI above 70
RSI is a technical indicator that measures the magnitude of recent price changes in a stock to evaluate its overbought or oversold status. Ranging from 0 to 100, RSI above 70 indicates overbought conditions, while RSI below 30 indicates oversold conditions
Tata Motors, Aarti Drugs among 10 overbought stocks with RSI above 70
On July 25, Tuesday, StockEdge reported a staggering number of 90 stocks trading in the overbought zone, indicating potential cautionary signals for investors
Alkem Laboratories forays into ophthalmology segment
The nationwide launch of the company's ophthalmology product range ensures that patients across India have access to quality eye-care formulations at an affordable price, the company said in a statement.